Ammonia is considered to be the main
neurotoxin responsible for
hepatic encephalopathy resulting from
liver failure.
Liver failure has been reported to alter expression and activity of
P-glycoprotein (P-gp) and
multidrug resistance-associated protein 2 (Mrp2) at the blood-brain barrier (BBB). The aim of this study was to investigate whether
ammonia is involved in abnormalities of expression and activity of P-gp and Mrp2 at the BBB. Hyperammonemic rats were developed by an
intraperitoneal injection of
ammonium acetate (NH4 Ac, 4.5 mmol/kg). Results showed that Mrp2 function markedly increased in cortex and hippocampus of rats at 6 h following NH4 Ac administration. Significant increase in function of P-gp was observed in hippocampus of rats. Meanwhile, such alterations were in line with the increase in
mRNA and
protein levels of P-gp and Mrp2. Significant increase in levels of nuclear amount of nuclear factor-κB (NF-κB) p65 was also observed. Primarily cultured rat brain microvessel endothelial cells (rBMECs) were used for in vitro study. Data indicated that 24 h exposure to
ammonia significantly increased function and expression of P-gp and Mrp2 in rBMECs, accompanied with activation of NF-κB. Furthermore, such alterations induced by
ammonia were reversed by NF-κB inhibitor. In conclusion, this study demonstrates that
hyperammonemia increases the function and expression of P-gp and Mrp2 at the BBB via activating NF-κB pathway.
Hyperammonemia, a proverbial main factor responsible for
neurocognitive disorder and blood-brain barrier (BBB) dysfunction resulting from
liver failure, could increase the expression and activity of
P-glycoprotein and
multidrug resistance-associated protein 2 (Mrp2) at the BBB both in vivo and in vitro. Furthermore, the NF-κB activation stimulated by
hyperammonemia may be the potential mechanism underlying such abnormalities induced by
hyperammonemia.